Skip to main content
AQVESME 100 mg/1 tablet, film coated by Agios Pharmaceuticals, Inc.
AQVESME, 100 mg/1, tablet, film coated Drug class: Pyruvate Kinase Activator. Available on prescription only. Listed by Agios Pharmaceuticals, Inc..
Prescription only

AQVESME

mitapivat

Listed by Agios Pharmaceuticals, Inc.

Strength
100 mg/1
Form
Tablet, Film Coated
Route
Oral
Class
Pyruvate Kinase Activator

What it contains

  • Mitapivat 100 mg/1

FDA record

Dosage form Tablet, Film Coated
Route Oral
Drug class Pyruvate Kinase Activator
Approval route NDA — original brand approval
NDC code 71334-235
FDA application NDA216196
RxNorm concept 2730660
Package sizes listed 1
Marketed since December 2025

Other products containing Mitapivat

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

PYRUKYND

mitapivat

Strength
5 mg/1
Form
Tablet, Film Coated
Class
Pyruvate Kinase Activator
Rx only

Agios Pharmaceuticals, Inc.

Not stocked by us — reference only

PYRUKYND

mitapivat

Strength
20 mg/1
Form
Tablet, Film Coated
Class
Pyruvate Kinase Activator
Rx only

Agios Pharmaceuticals, Inc.

Not stocked by us — reference only

PYRUKYND

mitapivat

Strength
5 mg/1
Form
Tablet, Film Coated
Class
Pyruvate Kinase Activator
Rx only

Agios Pharmaceuticals, Inc.

Not stocked by us — reference only

PYRUKYND

mitapivat

Strength
50 mg/1
Form
Tablet, Film Coated
Class
Pyruvate Kinase Activator
Rx only

Agios Pharmaceuticals, Inc.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.